NCT03860870View on ClinicalTrials.gov

Response to Clenbuterol in Humans

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

December 21, 2022

Study Completion Date

December 21, 2022

Conditions
Healthy
Interventions
DRUG

Clenbuterol Oral Product

Subjects ingest 4x20 microgram clenbuterol tablets

DRUG

Placebo

Subjects ingest placebo tablets

Trial Locations (1)

Unknown

August Krogh Building, Copenhagen

All Listed Sponsors
lead

University of Copenhagen

OTHER

NCT03860870 - Response to Clenbuterol in Humans | Biotech Hunter | Biotech Hunter